Cargando…

Select-agent status could slow development of anti-SARS therapies

Detalles Bibliográficos
Autor principal:	Matthews, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096004/ https://www.ncbi.nlm.nih.gov/pubmed/23223045 http://dx.doi.org/10.1038/nm1212-1722

Ejemplares similares

Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity
por: Rozanov, Dmitri, et al.
Publicado: (2019)

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
por: Houot, Roch, et al.
Publicado: (2020)

Status of mTCA Slow Control development at CMS
por: Volkov, Petr
Publicado: (2015)

Prion; the unconventional slow infectious agent.
por: Kim, Y. S.
Publicado: (1997)

Slow Virus Infections
por: Matthews, W.B.
Publicado: (1981)

Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
por: Park, Ji-Young, et al.
Publicado: (2012)

Slow wave activity across sleep-night could predict levodopa-induced dyskinesia
por: Amato, Ninfa, et al.
Publicado: (2023)

Status of slow ejection studies
por: Barbalat, O
Publicado: (1971)

Ayurvedic metal nanoparticles could be novel antiviral agents against SARS-CoV-2
por: Sarkar, Prasanta Kumar, et al.
Publicado: (2021)

CYP2D6 intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine
por: Pett, Helmi, et al.
Publicado: (2014)

Gene therapies development: slow progress and promising prospect
por: Hanna, Eve, et al.
Publicado: (2017)

Selective anti-cancer agents as anti-aging drugs
por: Blagosklonny, Mikhail V
Publicado: (2013)

China and SARS: could do better
Publicado: (2004)

Wild animals could be source of SARS
por: Bonn, Dorothy
Publicado: (2003)

The LARG Slow Control. Status Report
por: Poggioli, Luc
Publicado: (1998)

Status of studies of the CPS slow extraction
por: Baconnier, Yves, et al.
Publicado: (1970)

Status of the CPS slow ejection system
por: Hereward, H G, et al.
Publicado: (1968)

Status of studies on the CPS slow extraction
por: Baconnier, Y, et al.
Publicado: (1969)

Severe airport sanitarian control could slow down the spreading of COVID-19 pandemics in Brazil
por: Ribeiro, Sérvio Pontes, et al.
Publicado: (2020)

Altitudinal Barrier to the Spread of an Invasive Species: Could the Pyrenean Chain Slow the Natural Spread of the Pinewood Nematode?
por: Haran, Julien, et al.
Publicado: (2015)

Tumor immune microenvironment in therapy‐naive esophageal adenocarcinoma could predict the nodal status
por: Kotsafti, Andromachi, et al.
Publicado: (2022)

Could human bocavirus be a causative agent of parotitis in children?
por: Calvo, Cristina, et al.
Publicado: (2019)

Slow ejection developments
Publicado: (1970)

Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants
por: Blanquart, François, et al.
Publicado: (2022)

Slow extraction: Ripple compensation : status report
por: Dekkers, D, et al.
Publicado: (1968)

Current status of therapy of SARS
por: Lau, Arthur Chun-Wing, et al.
Publicado: (2005)

Novel agents for anti-platelet therapy
por: Ji, Xuebin, et al.
Publicado: (2011)

Could human bocavirus be a causative agent of parotitis in children?
por: Calvo, Cristina, et al.
Publicado: (2019)

Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Could Neonatal Hypernatremia Dehydration Influence Hearing Status?
por: Boskabadi, Hassan, et al.
Publicado: (2014)

Application of simultaneous selective pressures slows adaptation
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

Slow, slow, slow, quick quick, slow
Publicado: (1976)

How Inclusive, User-Centered Design Research Can Improve Psychological Therapies for Psychosis: Development of SlowMo
por: Hardy, Amy, et al.
Publicado: (2018)

The Role of Integrins in Cancer and the Development of Anti-Integrin Therapeutic Agents for Cancer Therapy
por: Lu, Xinjie, et al.
Publicado: (2008)

Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?
por: Ye, Byong Duk
Publicado: (2014)

Could neutrophil/lymphocyte ratio be an indicator of coronary artery disease, coronary artery ectasia and coronary slow flow?
por: Yılmaz, Mücahid, et al.
Publicado: (2016)

Coronavirus neuropathogenesis: could SARS be the tip of the iceberg?
por: Talbot, Pierre J, et al.
Publicado: (2008)

The pleotropic role of statins: Could it be the imminent host modulation agent in periodontics?
por: Grover, Harpreet Singh, et al.
Publicado: (2013)

The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2: Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents
por: Nanavaty, Vishal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ko8o8i5einlak3eapfc7cakosl